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Abstract : 
Purpose: The research aims to synthesis of 1,3-benzoxazine ring and evaluated their anticancer activity against human lung 
cancer (A549) and also their molecular docking studies approach, through methionyl-tRNA synthetase inhibition. 
Methodology: the successful of synthesis process, obtained 2-phenyl-4H-benzo[d][1,3]oxazin-4-one was evaluated by 1D NMR 
(1H-NMR and 13C-NMR), FTIR and UV spectra. The biological anticancer activity was evaluated by MTT Assay against human 
lung cancer (A549). Molecular docking studies was performed by Molegro Virtual Docker (MVD) version 5.5 as a software. The 
molecule target was docked into the active side on Methionyl-tRNA Synthetase (MRS),that was downloaded from www.pdb.org 
with PDB; ID 1PG2. 
Results: based on all spectra data (1H-NMR, 13C-NMR, FTIR dan UV) obtained 2-phenyl-4H-benzo[d][1,3]oxazin-4-one in very 
good yield  (90 %±2%’ n=6), their anticancer activity through MTT Assay Method against A549 Cancer Cell Line by triplicate, 
obtained IC50= 65.43 ±2.7 μg/mL and the result of molecular docking studies their rerank score -76.04 Kcal/mol, more higher 
than its native ligand (-93.50 Kcal/mol). 
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1.Introduction. 
Cancer is the biggest health problem to human both in the developed and developing countries (Ferley et al., 2019). According to 
the World Health Organization (WHO) 2015, the top 10 diseases causing the most deaths worldwide, one of them is lung cancer. 
Lung cancer ranks fifth out of 10 deadly diseases in the world. Based on existing data from 2000-2015 there was an increase in 
mortality of around 12 million to 17 million people each year ((Pietrangelo & Holland, 2017; Kesuma et al., 2018). Based on this 
problem, many researchers have been trying to investigate medicines to treat cancer because all medicines to treat cancer still 
have so many side effects, some could develop other cancer type (Joseph et. al., 2008). 
Benzoxazine are compounds that are quite interesting to study, in addition to their unique molecular structure (heterocyclic 
consist of  atoms C,N and O), also because it is known that benzoxazine derivatives have various biological activities (Coppola, 
1999). Several studies have reported benzoxazine derivatives have anticancer activity (Bharathkumar et al., 2015; Zilifdar et al., 
2014; Rudyanto at. al., 2015; Putra et al., 2016). Some of research were reported 1,3-benzoxazine ring has potential anticancer 
activity on inhibiting the growth of lung cancer through Methionyl-tRNA Synthetase Inhibition (Bharathkumar et al., 2015). 
MRS is a group enzyme have a function for transferring a specific amino acid to cognate tRNA to form aminoacyl-tRNA. This 
enzyme play rule for carrying the respective amino acid to the site of protein synthesis to begin translation at the initiation codon 
(Katzung et al., 2009; Finkel et al., 2009; Lüllmann et al., 2000 ). Increasing activity of MRS was reported in many evidence 
human cancers cell therefore MRS to be one targeted some of drug discovery to reduce cancers cell survival, proliferation and 
metastasis. 
In this research, we synthesized 2-phenyl-4H-benzo[d][1,3]oxazin-4-one, that were evaluated its activity against human lung 
cancer cells by in-vitro study through MTT Assay method and its in-silico study was determined by observing the energy binding 
of the  compound while interacting with Methionyl-tRNA Synthetase (MRS). In signal transduction path of cancer, Methionyl-
tRNA Synthetase (MRS) has an important role for the growth of cancer cells. Therefore by constructing compound which 
inhibited this enzyme, we have great opportunity to generate anticancer agents  
 
2.Material and Method 
2.1Synthesis 
All chemicals (anthranilic acid, benzoyl chloride, NaHCO3), solvents (Ethanol 90 %, ethyl acetate, n-henxane), and catalyst 
(pyridine)  were purchased from commercial branded such as Sigma Aldrich and Merck. Reactions were monitored with TLC 
silica gel 60, GF 254, 0.2 mm layer thickness was purchased from Merck. Mobile phase for TLC using n-hexane : ethyl acetate 
(1:1) and the spots were visualized under UV-ray (254 nm). Melting points was measured with an Electrothermal melting point 
apparatus innotech DMP-600. IR spectra was obtained using a Jasco FT-IR 5300 Perkin-Elmer spectrometer using KBr disks as 
media. 1D-NMR(1H- NMR and 13C-NMR) spectra were obtained on JEOL JNM-ECS 600 (1H-NMR: 600 MHz, 13C-NMR: 151 
MHz). We used DMSO-d6 as solven for 1H-NMR and 13C-NMR analysis. Chemical shifts were measured relative to internal 
standard Tetramethylsilane TMS (d: 0). MS spectra was measured with a JEOL JMS 600 spectrometer by using the ESI methods. 
 
Anthranilic acid (0.05 mol) was dissolved in 10 mL pyridine. Benzoyl chloride was dropped wisely at cool temperature (0°C) 
with constant stirring. After stirring for 1 hour at about room temperature (25 °C), add the saturated bicarbonate acid (10%). 
Addition of NaHCO3 solution (10%) was continued until the effervescence due to the evolution of carbon-dioxide ceased. Add 
some purified water and separated solid phase and liquid phase using Buchner. The purification of the solid phase was carried out 
by recrystallization using ethanol 90 % : aceton (5:1) (Noolvi et al., 2011; Noolvi & Patel., 2013; Rajasekhar et al., 2016; Putra et 
al., 2017). 
 
Figure 1. Synthesis of 2-phenyl-4H-benzo[d][1,3]oxazin-4-one from anthranilic acid (1) and benzoyl chloride (2) 
 
2.2MTT Assay against Human lung cancer cells (A549). 
Human lung cancer cells with code id A549 were got from Riken Cell Bank (Japan), and it was cultivated in an enhanced 
medium. The cell culture medium was used in this experiment was combination of 10% heat inactive FBS (Fetal Bovine Serum), 
DMEM (Dulbecco’s modified Eagle’s Medium), Amphotericin B (5.6 μg/mL) and Kanamycin (100μg/mL) both of antibiotics 
function to sterile the media, while 3 days-old cells was growth as test material. 1.00 μL of samples with the range of 
concentration 100-25 ppm (1% final concentration in DMSO solution) and 99.00 μL of A549 cells (5×103cells) were incubated 
with into a 96-well plate at 37°C for 3days or 72 hours. After removing medium and added 100.00 μL of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), incubated for another 1.5 hours at CO2 incubator. Final step was 
replaced MTT solution with DMSO. The absorbance was scanned at λ540 nm with a 2300 EnSpire Multimode plate reader by 
PerkinElmer, Inc. We was used Doxorubicin as standard in positive control. The result of MTT Assay was performed in triplicate 
and reported as mean ± standard deviation.  
 
2.3Molecular docking study 
In-silico study was performed by using MVD (Molegro® Virtual Docker version 5.5).CS ChemBioDraw Ultra ver 11.0 
(Cambridge Soft) was used to prepare compound 3 to building 3D chemical structure and to optimize their geometry structure 
were performed using MMFF94 energy (Thomas, 1996). Compound 3 was docked into the active side on Methionyl-tRNA 
Synthetase (MRS). MRS is a group enzyme have a function for transferring a specific amino acid to cognate tRNA to form 
aminoacyl-tRNA. They important play rule for carrying the respective amino acid to the site of protein synthesis to begin 
translation at the initiation codon. Increasing activity of MRS was reported in many evidence human cancers cell therefore the 
human MRS up-regulation in cancer renders it as a unique target and effective strategy to design inhibitors to reduce cancers cell 
survival, proliferation and metastasis (katzung et al., 2009; Bharathkumar et al., 2015). The structure of MRS enzyme (PDB ID: 
1PG2) was downloaded from the Protein Data Bank (www.rcsb.org). The validation of docking was carried out by redocking its 
native ligand of the enzyme, namely 2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol into its active site 
(Crepin et al., 2003). Criteria of acceptance is set with the value of Root Mean Square Deviation (RMSD) least than or equal 2.0 
Å. After redocking process, the compound 3  was docked into active site of MRS enzyme. The binding affinity between ligand 
and enzyme (docking score) was evaluated using Rerank Score. Rerank score is one of the main parameters in molecular docking 
study. It is interaction energy between ligand and receptor, they was calculated base on external and internal ligand interaction 
with their receptor (Thomsen & Christensen., 2006). The smaller Rerank score value means the more stable ligand-receptor 
bonding, which predicted as a higher biological activity 
 
 
Figure 2. Comparison of its native ligand (green) with the doking result simulation (blue) by 
Molegro Virtual Docker (MVD) software Ver.5.5. The RMSD is 0.84Å 
3.Result and Discussion 
3.1 Synthesis 
The reaction between anthranilic acid (1) and benzoyl chloride (2), they was dissolved in pyridine (free-water solvent) would be 
successfully synthesized and obtained 2-phenyl-4H-benzo[d][1,3]oxazin-4-one in very good yield (90 %±2%’ n=6). The 
mechanism of this reaction consist of two steps. The first step for mechanism of reaction is amine functional group of (1) as 
nucleophile attacks carbonyl center of (2) via SN-acyl (addition following by elimination) see Figure 3. Pyridine as a catalyst 
plays a role in deprotonation process of the hydrogen atom of amine functional group. This yielded to a tetrahedral intermediate 
product which continue to form 3’ shown at Figure 3. After that, the second step for mechanism of reaction is pyridine acted as 
deprotonating agent for carboxylic moiety of 3’ to yield carboxylate anion which then proceeded to attack the resulting amide 
group intramolecularly (Noolvi et al., 2011; Noolvi & Patel., 2013; Putra et al., 2017). This cyclization resulted to a benzoxazine 






























Figure 3. The first step for mechanism of reaction between anthranilic acid (1) and benzoyl chloride (2) to form 2-
benzamidobenzoic acid (3’) 
 
 
Figure 4. The second step for mechanism of reaction to form 2-phenyl-4H-benzo[d][1,3]oxazin-4-one 
 
Determination of compound (3) was confirmed by 1D NMR (1H-NMR, 13C-NMR), MS, and IR spectral data. The 1H-NMR 
spectrum of compound (3) showed peaks in the aromatic region around δ 7.57-8.19 ppm, indicating the existence of 9 protons of 
aromatic ring shown at Figure 5. Meanwhile, 13C-NMR similarly showed the presence of two aromatic rings shown at  Figure 6. 
The total of carbon atom are 14. Furthermore, the presence of carbonyl fragment at δ 158.8 ppm and imine fragment at δ 156.4 
ppm implied the formation of benzoxazine ring. Mass spectroscopy confirmed the compound 3 exhibited molecular weight of 
224.07 ([M+H]+) shown at Figure 7, with mass deviation of 0.16 (< 5mmu) from theoretical molecular weight. The 
fragmentation result confirmed the molecular formula of C14H9O2N. Ultimately, infrared spectrum data showed the formation of 
benzoxazine ring manifested in absorption band at 1764 cm-1 (C=O lactone bond) and 1614 cm-1 (-C=N bond) shown at Figure 
S8 (Pavia et al.,2009). 
 
Detailed physicochemical and spectral data of the obtained compound of 2-phenyl-(4H) benzo[1,3]oxazin-4-one 
Obtained in white crystals, mp: 118-119°C. 1H NMR (600 MHz, DMSO-d6) δ 8.18 (dd, J = 7.7, 1.7 Hz, 2H), 8.14 (dd, J = 7.8, 
1.6 Hz, 1H), 7.93 (td, J = 7.7, 1.6 Hz, 1H), 7.70 (d, J = 7.9 Hz, 1H), 7.67 – 7.64 (m, 1H), 7.63 – 7.57 (m, 3H). The total of 
hydrogen atom are 9 atoms. 13C-NMR (151 MHz, DMSO) δ 158.8, 156.4, 146.2, 136.8, 132.7, 130.0, 128.9 (2C), 128.5, 128.0, 
127.8 (2C), 126.9, 116.9, The total of carbon atom are 14 atoms. FT-IR (KBr) cm-1 : 1764 (C=O lacton); 1599 and 1474 (C=C 
aromatic); 3040 (=C-H aromatic); 1614 (C=N); 1315 (C-N). ESI-MS m/z, [M+H]+=224. All these spectral data are in agreement 
with the structure of 2-phenyl-4H-benzo[1,3]oxazin-4-one 
 
 
Figure 5. 1H-NMR spectrum of 2-phenyl-4H-benzo[d][1,3]oxazin-4-one in (600 MHz, DMSO-d6) 
 
 
Figure 6. 13C-NMR spectrum of 2-phenyl-4H-benzo[d][1,3]oxazin-4-one in (151 MHz, DMSO-d6) 
 
 
Figure S7. MS spectrum of 2-phenyl-4H-benzo[d][1,3]oxazin-4-one by ESI Method 
 
 
Figure 8. FT-IR spectrum of 2-phenyl-4H-benzo[d][1,3]oxazin-4-one in KBr pellet 
3.2 Biological Assay 
The result of MTT Assay against Human lung cancer cells (A549), compound (3) has anticancer activity with value of IC50 = 
65.43 ±2.7 μg/mL as same as another research were reported by Bharathkumar et.al in 2015. Compound (3) have anticancer 
activity with IC50 value least than 100 μg/mL event though doxorubicin as positive control have IC50 value (14.61±2.3 μg/mL) 
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lower than compound (3) see table 1. The core structure of 1,3-benzoxazine ring was still believed have anticancer activity on 
inhibiting the growth of lung cancer although need optimize with another substituent to increasing potentially their activity. 
 
 
Tabel 1. The IC50 value of Human lung cancer cells (A549) growth inhibitory activity 
 









3.3 In-silico study 
Based on molecular docking result (Table 2; Figure 9), it is shown that compound 3 has rerank score -76.04 ±0.03 Kcal/mol 
(n=3) more higher than its native ligand rerank score -93.48 ±0.07 Kcal/mol (n=3).  Interaction between Compound  3 with 
Methionyl-tRNA Synthetase (MRS) showed  just only steric interactions on residues such as Gly 23; His 24; His 323; Gly 324; 
Val 326. It is different with interaction between its native ligand with their enzyme, not only steric interactions (His 21 and Glu 
27) but also it has hydrogen bond on amino acid residues such as Glu 27; His 28; Gly 294; Asp 296;Val 326, therefore rerank 
score of its native ligand more lower than compound 3, that means their native ligand more suitable interaction with MRS. 
 
  
Tabel 2. Molecular docking result on Methionyl-tRNA Synthetase (MRS) active site  





































Compound 3 Compound 3 
 
Native Ligand Native Ligand 
 
Figure 9. The Interaction between its native ligand and compounds 3 into active site Methionyl-tRNA Synthetase (MRS) 
 
4. Conclusion 
In this research we successfully synthesized  2-phenyl-4H-benzo[d][1,3]oxazin-4-one from starting material from anthranilic acid 
and benzoyl chloride  in very good yields (90 %±2%’ n=6). The compound of  2-phenyl-4H-benzo[d][1,3]oxazin-4-one shown 
anticancer activity on inhibiting the growth of human lung cancer cell (A549) with IC50= 65.43 ±2.7 μg/mL even though  their 
anticancer activity lower than Doxorubicin, and also it has rerank score more higher than its native ligand when docked onto 
Methionyl-tRNA Synthetase (MRS) (PDB code:1PG2). On the other hand, we still believe if  the core structure of 1,3-
benzoxazine ring has anticancer activity on inhibiting the growth of lung cancer although they need optimize with another 
substituent to increasing potentially their activity. 
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